Albumin Market Report：the market size is projected to reach USD 10.59 billion by 2031

Albumin is a crucial protein found in blood plasma, primarily produced by the liver. It plays a vital role in maintaining oncotic pressure, which helps regulate fluid balance between blood vessels and surrounding tissues. Additionally, albumin serves as a carrier protein, transporting hormones, fatty acids, drugs, and other substances throughout the body. It is essential for maintaining proper blood volume and preventing edema, making it a key component in overall circulatory and metabolic health.

Clinically, albumin levels are used as an important indicator of liver and kidney function. Low albumin levels may indicate liver disease, malnutrition, or nephrotic syndrome, while elevated levels are less common but may result from dehydration. In medical treatments, intravenous albumin solutions are used for conditions such as severe burns, shock, and hypoalbuminemia. Due to its vital functions, albumin is extensively studied in biomedical research, with ongoing developments in synthetic and recombinant albumin products for therapeutic use.

The albumin market is driven by the rising prevalence of liver diseases, kidney disorders, and hypoproteinemia, which require albumin therapy. Additionally, the growing use of albumin in critical care, such as treating burns, shock, and sepsis, is fueling demand. Expanding applications in drug delivery, vaccine formulation, and regenerative medicine are also key factors driving market growth. Moreover, the increasing geriatric population and advancements in recombinant and synthetic albumin production are expected to boost market expansion, particularly in developed healthcare markets.

However, the market faces challenges such as high production costs and supply constraints, particularly for human serum albumin, which relies on plasma collection. Stringent regulatory approvals for plasma-derived products and concerns regarding pathogen transmission further hinder market growth. Additionally, competition from alternative therapies, including synthetic colloids and plant-based albumin substitutes, may impact demand. Market players must address supply chain limitations, invest in recombinant albumin production, and navigate complex regulatory landscapes to sustain growth in this competitive industry.

According to the new market research report “Albumin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Albumin market size is projected to reach USD 10.59 billion by 2031, at a CAGR of 6.5% during the forecast period.

• Global Albumin MarketSize(US$ Million), 2020-2031

Source: QYResearch, "Albumin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

• Global Albumin Top19Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)

Source: QYResearch, "Albumin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

According to QYResearch Top Players Research Center, the global key manufacturers of Albumin include Takeda, CSL, Grifols, Octapharma, Tiantan Bio, etc. In 2024, the global top five players had a share approximately 65.0% in terms of revenue.

About The Authors

Zhang Xiao - Lead Author

Email: zhangxiao@qyresearch.com

Zhang Xiao is a market senior analyst specializing in medical device, pharma, Lab consumable. Zhang  Xiao has 8 years’ experience in medical device and  pharma market analysis, and focuses on medical device and consumables (imaging equipment, medical consumables, wearable medical equipment, medical robots, home care equipment, dental equipment, implant equipment, operating room equipment, in vitro diagnostics, etc.) and drugs (API, finished drugs, patented drugs, blood products , vaccines, etc.) . She is engaged in the development of technology and market reports and is also involved in custom projects.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp